Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jazz Pharma Plc (NQ: JAZZ ) 108.44 -1.26 (-1.15%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Jazz Pharma Plc < Previous 1 2 ... 5 6 7 8 9 10 11 12 Next > 3 Biotech Stocks That Are Too Cheap to Ignore September 02, 2021 You'll definitely want to check out these biotech bargains. Via The Motley Fool Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates August 31, 2021 August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining. New... Via Benzinga Canada Approves Jazz Pharma's Excessive Daytime Sleepiness Med August 31, 2021 Health Canada has approved Jazz Pharmaceuticals plc's (NASDAQ: JAZZ) Sunosi (solriamfetol) for excessive daytime sleepiness (EDS) associated with narcolepsy or... Via Benzinga Got $4,000? Buy These 2 Cannabis-Focused Biotech Stocks August 31, 2021 Neither of them needs to sell marijuana to consumers to succeed. Via The Motley Fool Topics Cannabis Exposures Cannabis The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight August 08, 2021 Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... Via Benzinga Exposures Product Safety 10 Small And Mid-Cap Growth Stocks To Buy Today August 18, 2021 If you are looking for long-term growth, you will most likely find it in small and mid-cap stocks because they have the room to grow. The bigger a company gets, the more difficult it is to achieve... Via Talk Markets This Cannabis Stock Is Full of Potential and Hasn't Been This Cheap in Months August 17, 2021 Investors have been selling off the stock since the company released its earnings report earlier this month. Via The Motley Fool Topics Cannabis Exposures Cannabis 10 Biggest Price Target Changes For Monday August 16, 2021 UBS boosted the price target on Seagate Technology Holdings plc (NASDAQ: Via Benzinga The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow August 15, 2021 Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among... Via Talk Markets Topics Initial Public Offering Exposures Securities Market The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow August 15, 2021 Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-... Via Benzinga Topics Initial Public Offering Exposures Securities Market GW Pharmaceuticals' Cannabidiol For Seizures Wins UK Approval August 10, 2021 The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) has approved GW Pharmaceuticals' cannabidiol as an adjunctive treatment of seizures... Via Benzinga Watch Medical Marijuana & Unrivaled Brands At The Benzinga Cannabis Hour August 06, 2021 Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday's show, hosts ... Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Daily Podcast 8/5: Europe Expansion And Buy The Dip Opportunity Stocks August 05, 2021 Start The Day With The Best Daily Pre-Market Overview Of The Can... Via Benzinga Topics Cannabis Exposures Cannabis The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO August 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma August 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety Innovators in Pharma Sectors See Potential, Promise in Providing Improved Treatments August 05, 2021 Via FinancialNewsMedia Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Call Transcript August 03, 2021 JAZZ earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Recap: Jazz Pharmaceuticals Q2 Earnings August 03, 2021 Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 5.12% over the past... Via Benzinga Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates August 02, 2021 The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi... Via Benzinga Jazz Pharmaceuticals's Earnings: A Preview August 02, 2021 Jazz Pharmaceuticals (NASDAQ:JAZZ) releases its next round of earnings this Tuesday, August 03. Get the latest predictions in Benzinga's essential guide to the company's Q2... Via Benzinga Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill? Operators Believe So. July 29, 2021 Cannabis operators and executives tell Benzinga that the movement of private and public companies may serve as a better indicator of regula... Via Benzinga Topics Cannabis Exposures Cannabis Is Jazz Pharmaceuticals Stock a Buy? July 24, 2021 Jazz Pharma is not the most popular drugmaker, but it is definitely worth a second look. Via The Motley Fool The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More July 02, 2021 Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021. Justice Thomas&nbs... Via Benzinga Topics Cannabis Exposures Cannabis Global Cannabis Stocks Decline 8.7% in Q2, Agrify, KushCo Among Strongest Cannabis Names In June July 02, 2021 The Global Cannabis Stock Index fell for the fourth straight month, dropping 4.1% to 57.10. During the second quarter, the index was down... Via Benzinga Topics Cannabis Exposures Cannabis The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts July 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE... Via Benzinga Exposures Product Safety Jazz Pharma's Rylaze Scores FDA Approval For Blood Cancer July 01, 2021 The FDA has approved Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the treatment of acute lymphoblastic... Via Benzinga Exposures Product Safety Got $5,000? These 3 Stocks Are Ridiculously Cheap Buys June 29, 2021 They are great options whether you are investing for the short or long term. Via The Motley Fool Topics Cannabis Exposures Cannabis Finding Value In Mid-Cap Stocks June 24, 2021 Within the mid-cap space there is something for everyone. Via Talk Markets New Cannabinoid-Based Drug Candidates from Artelo Biosciences Show Promise as Cancer and Mental Health Treatments; Key Data Due Before Year End June 24, 2021 The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or... Via Benzinga 14 Biotech Stocks To Watch Over The Next 6 Months June 23, 2021 Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:... Via Benzinga < Previous 1 2 ... 5 6 7 8 9 10 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.